Annual Current Ratio
4.13
-2.46-37.33%
December 31, 2023
Summary
- As of February 7, 2025, IKT annual current ratio is 4.13, with the most recent change of -2.46 (-37.33%) on December 31, 2023.
- During the last 3 years, IKT annual current ratio has risen by +1.00 (+31.95%).
- IKT annual current ratio is now -60.55% below its all-time high of 10.47, reached on December 31, 2021.
Performance
IKT Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
0.85
-1.47-63.36%
September 30, 2024
Summary
- As of February 7, 2025, IKT quarterly current ratio is 0.85, with the most recent change of -1.47 (-63.36%) on September 30, 2024.
- Over the past year, IKT quarterly current ratio has dropped by -1.47 (-63.36%).
- IKT quarterly current ratio is now -96.70% below its all-time high of 25.73, reached on June 30, 2021.
Performance
IKT Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
IKT Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | -63.4% |
| 3 y3 years | +31.9% | -91.8% |
| 5 y5 years | +1080.0% | -91.8% |
IKT Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.5% | at low | -91.9% | at low |
| 5 y | 5-year | -60.5% | >+9999.0% | -96.7% | +8400.0% |
| alltime | all time | -60.5% | >+9999.0% | -96.7% | +8400.0% |
Inhibikase Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.85(-63.4%) |
| Jun 2024 | - | 2.32(-9.0%) |
| Mar 2024 | - | 2.55(-38.3%) |
| Dec 2023 | 4.13(-37.3%) | 4.13(-35.5%) |
| Sep 2023 | - | 6.40(-20.4%) |
| Jun 2023 | - | 8.04(-22.5%) |
| Mar 2023 | - | 10.37(+57.4%) |
| Dec 2022 | 6.59 | 6.59(-24.3%) |
| Sep 2022 | - | 8.71(+15.2%) |
| Jun 2022 | - | 7.56(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 8.76(-16.3%) |
| Dec 2021 | 10.47(+234.5%) | 10.47(-38.2%) |
| Sep 2021 | - | 16.94(-34.2%) |
| Jun 2021 | - | 25.73(+677.3%) |
| Mar 2021 | - | 3.31(+5.8%) |
| Dec 2020 | 3.13(>+9900.0%) | 3.13(>+9900.0%) |
| Sep 2020 | - | 0.01(0.0%) |
| Jun 2020 | - | 0.01(0.0%) |
| Mar 2020 | - | 0.01(0.0%) |
| Dec 2019 | 0.01(-97.1%) | 0.01 |
| Dec 2018 | 0.35 | - |
FAQ
- What is Inhibikase Therapeutics annual current ratio?
- What is the all time high annual current ratio for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual current ratio year-on-year change?
- What is Inhibikase Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly current ratio year-on-year change?
What is Inhibikase Therapeutics annual current ratio?
The current annual current ratio of IKT is 4.13
What is the all time high annual current ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual current ratio is 10.47
What is Inhibikase Therapeutics annual current ratio year-on-year change?
Over the past year, IKT annual current ratio has changed by -2.46 (-37.33%)
What is Inhibikase Therapeutics quarterly current ratio?
The current quarterly current ratio of IKT is 0.85
What is the all time high quarterly current ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly current ratio is 25.73
What is Inhibikase Therapeutics quarterly current ratio year-on-year change?
Over the past year, IKT quarterly current ratio has changed by -1.47 (-63.36%)